100 results
Page 3 of 5
8-K
EX-99.1
n8b67gy6t876ix4ig
1 Oct 19
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
8:14am
8-K
g9rdytt2
1 Oct 19
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
8:14am
8-K
EX-10.1
adeay1rltc2en8opngx
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K/A
EX-99.1
yz3f7t1ymyv8tl
27 Feb 19
CORRECTING and REPLACING — Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
5:16pm
8-K
EX-99.1
1i1dy56kgv 5w
27 Feb 19
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
7:43am
CORRESP
3b6pjq xsbwmmrmh00l
18 Oct 18
Correspondence with SEC
12:00am
8-K
EX-99.1
nlmkwaxqh4i s5rnab0
24 Jul 18
GSK and Adaptimmune Complete Transition of NY-ESO SPEAR T-cell Therapy Program to GSK
7:36am